CNBC Reports: "Elon Musk's Neuralink Raises $200 Million in New Funding Round" In a significant development, Elon Musk's neurotechnology firm Neuralink has secured $200 million in a new funding round, further fueling speculation about the company's ambitious plans to integrate the human brain with computers. Founded in 2016, Neuralink aims to develop implantable brain–machine interfaces (BMIs) that could potentially treat a range of medical conditions, from paralysis to depression. The new funding brings Neuralink's total valuation to an estimated $5 billion, underscoring investor confidence in the company's vision. As Neuralink continues to push the boundaries of neurotechnology, experts are eagerly awaiting updates on the company's progress and potential applications of its groundbreaking technology.